Share

    


Home / Search Results

Search Results

You searched for:

Teri Bedard, RT(R)(T), CPC, shares her highlights of the calendar year 2023 MPFS proposed rule and its potential impact on oncology/hematology.
ACCC Director Cancer Care Delivery and Health Policy Matt Devino, MPH, lays out the four key differences between the OCM and EOM that interested applicants need to consider.
This week, Congress passed a $1.5 trillion omnibus spending package for fiscal year 2022 with broad bipartisan support. Included in the domestic appropriations are several key healthcare provisions of interest to ACCC and the cancer care community.
Beginning January 2022, CMS will be required to cover for Medicaid patients the routine costs associated with participating in clinical trials. Learn what states and provider organizations can do to leverage this mandate to address barriers to care in the community and reduce inequities in clinical trial participation.
By Christian G. Downs, MHA, JD On Oct. 5, ACCC provided comments to the Centers for Medicare & Medicaid Services (CMS) on the agency’s proposed CY 2021 Outpatient Prospective Payment System (OPPS) and Physician Fee Schedule (PFS) rules. CMS is expected to release the final CY 2020 Medicare payment rules in early December. Below are highlights from ACCC’s comment letters. Specific to the proposed …
“In this town, we’ve seen healthcare become a political lightning rod,” U.S. Senator Debbie Stabenow (D-MI) told attendees on March 5 at the ACCC 46th Annual Meeting & Cancer Center Business Summit (AMCCBS) in Washington, D.C. As our nation grapples with unprecedented challenges—both individually and collectively—posed by the world-wide novel COVID-19 outbreak, it seems as though lightning has …
In this election year, U.S. healthcare policy is center stage. ACCC is monitoring proposed rules and policy changes to gauge their impact on cancer care access and delivery. ACCC Responds to CMMI on Oncology Care First Model ACCC provided comments to the Center for Medicare and Medicaid Innovation’s (CMMI's) request for information on its concept for the Oncology Care First (OCF) Model. While applauding …
In this election year, U.S. healthcare policy is center stage. ACCC is monitoring proposed rules and policy changes to gauge their impact on cancer care access and delivery. Recent policy actions include the Centers for Medicare & Medicaid Services (CMS) release on Feb. 5 of CY 2021/2022 Medicare Advantage and Part D Proposed Rule that would: Require Part D plans to offer real-time drug price …
Friday, Nov. 1 was a busy day for the Centers for Medicare & Medicaid Services (CMS) and its Center for the Medicare and Medicaid Innovation (CMMI). CMS released the final calendar year (CY) 2020 Hospital Outpatient Prospective System and Physician Fee Schedule final rules. Later that afternoon, CMMI posted an “informal” Request for Information on a proposal for the next iteration of an …
While federal law requires Medicare and private payers to cover the costs patients with cancer incur when participating in clinical trials, more than 42 million Medicaid enrollees—20 percent of the United States population—remain without such coverage. This coverage gap can have very real consequences for patients with cancer, as clinical trials not only produce essential research, but are also often …
The future of healthcare is at a crossroads. In the past year, the Trump Administration and Congress have made several proposals to address the rising costs of healthcare and drugs­, which have the potential to dramatically affect the landscape of cancer care. Now more than ever, the voices of professionals on the front lines of cancer care are crucial to shaping the direction of future …
On July 25, 2018, the Centers for Medicare & Medicaid Services (CMS) released the CY 2019 Outpatient Prospective Payment System (OPPS) proposed rule, and we are seeing several efforts to continue the push towards “site neutral” payments in off-campus provider-based departments (PBDs). This rule was issued weeks after the CY 2019 Physician Fee Schedule (PFS) proposed rule, and the atypical lag time …